apteka.lviDrugs24.com

Monthly offers  -Prices-Offer price Monthly offers 
Latvian pharmacies maps Duty doctors. medicaid
Medicines and generics searching-PricesDrugs search by alphabet
Vaccination offers. Pricelists-Prices-Offer price Vaccination offers
Space Weather Space weather
    
Queues for medical examinationsLists of compensated medicines        E‑health         
 LV 

PREGABALIN ZENTIVA 150MG N14

Attention: Information on this site is provided for informational purposes and is not meant to substitute for the advice provided by your own physician or other medical professional. You should not use the information contained herein for treating a health problem or disease, or prescribing any medication. iDrugs24.com is not responsible for any damage to your health as the result of self treatment.

# On 2024-Mar-28
PREGABALIN-drug/medicine aproximate price on "PREGABALIN ZENTIVA 150MG N14" in Riga city, Latvia is:
  • 13.61€  14.72$  11.67£  1572Rub  156.6SEK  59PLN  53.87₪ 


Maximum allowed state defined price ( from ZVA webpage) Euro:State defined maximum allowed price indicated on the picture on drug/medicine  PREGABALIN ZENTIVA 150MG N14     Recheck

Reģ. Nr.: EU/1/15/1021/017

ATC codeN02BF02 

Active substances: Pregabalinum

 


Vendor, principal: Zentiva

 Prescription drug (℞) 

Similar or the same name medicines, products list *
Medicament / Item title  Prices Pharmacies chain
PREGABALIN ZENTIVA KÕVAKAPS. 150MG N14, pregabaliin Rx
4.01€, Mar.2024 Pharmacy Estonia Aptev.ee, OÜ Mai apteek (Estonia) Phone: 6008844Buy
PREGABALIN ZENTIVA CAPS 150MG N14
4.01€, Mar.2024 Pharmacy Estonia Valga südameapteek (Estonia) Phone: +3727668005Buy
PREGABALIN ZENTIVA CAPS 150MG N14
4.01€, Mar.2024 Pharmacy Estonia Valga selveri apteek. Apotheka.ee (Estonia) Phone: +3727661766 Buy
PREGABALIN ZENTIVA K.S KÕVAKAPS. 150MG N14, pregabaliin Rx
4.14€, Mar.2024 Pharmacy Estonia Aptev.ee, OÜ Mai apteek (Estonia) Phone: 6008844Buy
PREGABALIN ZENTIVA 150 MG KAPSULĖS N56 (Zentiva, k.s.)
9.11€, Jan.2024 Internet pharmacy Lithuania 100 metų vaistinė (Lithuania) Phone: +37038159292Buy
PREGABALIN ZENTIVA 150 MG KIETOSIOS KAPSULĖS N56
9.11€, Mar.2024 Internet pharmacy Lithuania Gintarinė vaistinė nvaistine.lt (Lithuania) Phone: 880010008Buy
PREGABAL.ACCORD 150MG N14 Rx (Accord)
9.52€ , Feb.2024 Internet pharmacy Latvija internetaptieka.lv T. 26699176, Address: Riga, Dzelzavas street 120M, LV-1021. Opening hours: Working days: 9.00-18.00. Prescription medicines can be received in person with a prescription or identity document, or ordered with delivery, if an e-prescription has been issued.Real final price may be varied.
PREGABALIN ZENTIVA CAPS 150MG N56
16.06€, Mar.2024 Pharmacy Estonia Benu Apteek (Estonia) Phone: +3726119070Proceed with order
PREGABALIN ZENTIVA KÕVAKAPS. 150MG N56, pregabaliin Rx
16.06€, Mar.2024 Pharmacy Estonia Aptev.ee, OÜ Mai apteek (Estonia) Phone: 6008844Buy
PREGABALIN ZENTIVA CAPS 150MG N56
16.06€, Mar.2024 Pharmacy Estonia Valga südameapteek (Estonia) Phone: +3727668005Buy
* This table was compiled fully automatically, independently from any advertisers, transparently and without any modification relaying the open offers available on the mentioned dates.Only the distribution of over-the-counter remedies through the website is permitted in Latvia in accordance with national laws and regulations.

EUROPEAN MEDICINES AGENCY

SCIENCE MEDICINES HEALTH

EMA/351750/2015

EMEA/H/C/003900

EPAR summary for the public

Pregabalin Zentiva

pregabalin

This is a summary of the European public assessment report (EPAR) for Pregabalin Zentiva. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to use Pregabalin Zentiva.

For practical information about using Pregabalin Zentiva, patients should read the package leaflet or contact their doctor or pharmacist.

What is Pregabalin Zentiva and what is it used for?

Pregabalin Zentiva is a medicine used to treat adults with the following conditions:

•   epilepsy, where it is used as an Nadd-on' to existing treatment in patients who have partial seizures (epileptic fits starting in one specific part of the brain) that cannot be controlled with their current treatment;

•   generalised anxiety disorder (long-term anxiety or nervousness about everyday matters).

Pregabalin Zentiva is a generic medicine'. This means that Pregabalin Zentiva is similar to a Reference medicine' already authorised in the European Union (EU) called Lyrica. For more information on generic medicines, see the question-and-answer document here.

Pregabalin Zentiva contains the active substance pregabalin.

How is Pregabalin Zentiva used?

Pregabalin Zentiva is available as capsules (25, 50, 75, 100, 150, 200, 225 and 300 mg) and can only be obtained with a prescription. The recommended starting dose is 150 mg per day, divided into two or three doses. After three to seven days, the dose can be increased to 300 mg per day. Doses can be increased up to twice more until the most effective dose is reached. The maximum dose is 600 mg per

An agency of the European Union

WC5EN00190752

30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact

© European Medicines Agency, 2015. Reproduction is authorised provided the source is acknowledged.

day. Stopping treatment with Pregabalin Zentiva should also be done gradually, over at least a week. Doctors may need to lower the dose in patients who have kidney problems.

How does Pregabalin Zentiva work?

The active substance in Pregabalin Zentiva, pregabalin, is similar in structure to the body's own Nneurotransmitter' gamma-amino butyric acid (GABA), but has very different biological effects. Neurotransmitters are chemicals that allow nerve cells to communicate with each other. The exact way that pregabalin works is not fully understood, but it is thought to affect the way that calcium enters nerve cells. This reduces the activity of some of the nerve cells in the brain and spinal cord, reducing the release of other neurotransmitters that are involved in epilepsy and anxiety.

How has Pregabalin Zentiva been studied?

Because Pregabalin Zentiva is a generic medicine, studies in people have been limited to tests to determine that it is bioequivalent to the reference medicine, Lyrica. Two medicines are bioequivalent when they produce the same levels of the active substance in the body.

What are the benefits and risks of Pregabalin Zentiva?

Because Pregabalin Zentiva is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine's.

Why is Pregabalin Zentiva approved?

The Agency's Committee for Medicinal Products for Human Use (CHMP) concluded that, in accordance with EU requirements, Pregabalin Zentiva has been shown to have comparable quality and to be bioequivalent to Lyrica. Therefore, the CHMP's view was that, as for Lyrica, the benefit outweighs the identified risk. The Committee recommended that Pregabalin Zentiva be approved for use in the EU.

What measures are being taken to ensure the safe and effective use of Pregabalin Zentiva?

A risk management plan has been developed to ensure that Pregabalin Zentiva is used as safely as possible. Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Pregabalin Zentiva, including the appropriate precautions to be followed by healthcare professionals and patients.

Further information can be found in the summary of the risk management plan.

Other information about Pregabalin Zentiva

The European Commission granted a marketing authorisation valid throughout the European Union for Pregabalin Zentiva on 17 July 2015.

The full EPAR and risk management plan summary for Pregabalin Zentiva can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports. For more information about treatment with Pregabalin Zentiva, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.

The full EPAR for the reference medicine can also be found on the Agency's website.

This summary was last updated in July-2015.

Page 2/2

Pregabalin Zentiva EMA/351750/2015



 Instruction , annotation source: The European Medicines Agency


[*1]

DDD. Information source: WHO Collaborating Centre for Drug Statistics Methodology. Norwegian Institute of Public Health


Back


Facebook Tweeter E-mail link
For pharmacies & healthstores For advertisers About

Copyright © 2011-2024 iDrugs24.com. All rights reserved